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Abstract Modern evolutionary research has much to
contribute to medical research and health care practices.
Conversely, evolutionary biologists are tapping into the
rapidly expanding databases of medical genomic informa-
tion to further their research. These two fields, which have
historically functioned in almost complete isolation, are
finding mutual benefit in the exchange of information. The
long-term benefits of this synthesis of two major areas of
research include improved health care. Recently, efforts to
catalyze this relationship have brought together evolution-
ary biologists, medical practitioners, anthropologists, and
ethicists to lay the groundwork for further collaboration and
exploration. The range of overlap is surprisingly broad and
potentially invaluable.
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Evolution and Medicine
Evolution has not traditionally been considered to be an
important aspect of medicine, and medical practitioners and
researchers have not traditionally approached their work
from the perspective offered by evolutionary biology.
Medical practice tends to focus on the immediate, or
proximate, causes of disease, including genetics and
lifestyle, to identify a potential treatment. An evolutionary
viewpoint pushes the focus out farther to look at long-term
ecological relationships, including symbiotic bacteria, para-
sites and pathogens, historical lifestyles, and the genetics of
populations. Conversely, evolutionary biologists have not
traditionally paid much attention to the medical implica-
tions or applications of their findings, with a few exceptions
such as the study of emerging infectious diseases. Other
evolutionary studies have seemed far removed from
contemporary human health issues.
Recently, however, these traditions have been giving way
to a new approach, as researchers and medical practitioners
discover connections based on evolutionary biology that are
leading them to new conclusions about their respective fields.
Evolution is providing clues about puzzling medical results,
and studies of human health are giving us new information
about the rate and driving forces of evolution. Initiatives such
as the Human Genome Project and the Haplotype Map have
provided new tools for studying evolution and human health.
Genes are important, environment is important, the interaction
between the two is important—but so is human evolution, as it
exerts an ongoing influence on characteristics of the human
population.
In May 2007, evolutionary and medical researchers,
doctors, ethicists, and anthropologists met at the National
Evolutionary Synthesis Center to catalyze the emerging
scientific discipline known as evolutionary medicine. Al-
though the participants work on different aspects of human
health, they all realize the value of evolution in their work.
As the title of the meeting—Evolution in Contemporary
Human Populations: Medical, Genetic and Behavioral
Implications (Govindaraju 2007)—suggests, this group of
scientists clearly share the belief that evolution is going on in
contemporary human populations. In fact, a recent study
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presents evidence that evolution may have been occurring
even faster in human populations than expected over the past
10,000 years (Hawks et al. 2007).
The field of medicine has developed to address the wide
array of environmental and lifestyle-induced diseases. Over
time, doctors have learned more about the relationship
between environment and disease, including factors such as
hygiene and lifestyle. More recently, genomic studies have
opened the door to studying genetic differences between
populations, bringing us the possibility of more effective
individualized medicine. All in all, medicine seems to be
making great progress in preventing, treating, and curing
disease without including evolutionary information. So
what does understanding our evolutionary history add to
our ability to improve human health?
Shaped by History
It has been shown that human evolution, in the form of
natural selection for particular traits, can occur over the short
term—just a few generations, “the blink of an eye to
evolutionary biologists,” according to Yale University
evolutionary biologist Stephen Stearns, one of the NESCent
meeting organizers. Continued lactose tolerance in adults is
an example of a trait that has evolved in certain populations
within the last 10,000 years, since the domestication of milk-
producing livestock (Tishkoff et al. 2006; Swallow 2003). “If
a doctor can become aware of how all these different traits
actually interact with each other, then you begin to see your
individual patient as something that isn’t just the symptom
sitting in front of you in the office that day,” Stearns says. “If
you treat that symptom, then the perspective of evolutionary
biology will tell you what all of the possible associated
reactions are. The point is, they’re a bit broader, and they
may contain more surprises than a strictly medical orienta-
tion would give you. Evolution gives you a broader view of
the whole way an organism reacts, and why it does so—
because it’s been shaped by evolution in certain ways.”
Psychiatrist Randolph Nesse of the University of Michigan, a
strong advocate of evolutionary medicine, agrees: “Once a
doctor starts understanding how the body came to be, instead
of seeing the body as a machine—which it’s not—he or she
starts seeing the body as a product of natural selection, where
everything in the body is pretty good, because it’s got to be,
and nothing is perfect….This perspective is needed for
literally every aspect of the body that’s vulnerable to disease.
Why hasn’t natural selection made it better? There are
always good reasons.”
Among those reasons is the idea that evolution involves
an array of trade-offs, compromises in selection that favor
one trait at the inevitable expense of another. Stearns,
Nesse, and David Haig of Harvard University eloquently
explain the importance of evolutionary trade-offs in the
initial chapter of Evolution in Health and Disease (Stearns
and Koella 2007):
No trait is perfect. Every trait could be better, but making
it better would make something else worse. Our vision
could be as acute as that of an eagle, but the price would
be a decreased capacity to detect color, depth, and
movement in a wide field of vision. If the bones in our
wrists were thicker they would not break so readily, but
we would not be able to rotate our wrists in the wonderful
motion that makes throwing efficient. It the stomach
made less acid we would be less prone to ulcers, but
more prone to GI infections. Every trait requires analysis
of the trade-offs that limit its perfection.
Consideration of these compromises that have evolved
over time can guide medical decisions about altering our
physiology and behaviors.
The evolutionary trade-off between survival and repro-
ductive success of the individual is an interesting example.
Reproduction is expensive, on many fronts. Just looking at
mating success, high testosterone levels may provide a man
with a competitive advantage in securing a mate, but will
also decrease his resistance to pathogens and parasites
(Muehlenbein and Bribiescas 2005). A woman who has
regular and frequent menstrual cycles has more opportuni-
ties to become pregnant, but is also at increased risk of
cancer (Strassmann 1999). Exposure to higher hormone
levels, either incidentally or by design, can have unexpected
side effects because of this evolutionary trade-off. Repro-
ductive success is ultimately the more important factor in
evolution, as one’s evolutionary fitness is measured by the
number of offspring that survive to reproductive age
themselves. The compromise results from the fact that we
produce only one or two offspring at a time, and human
offspring require extended parental care. Humans who threw
everything into mating but did not survive long enough to
raise the few resulting offspring would be unsuccessful
because their offspring would not survive either. Radically
changing traits that have been shaped over time runs the very
real risk of tipping the balance in unexpected, and potentially
unpleasant, directions.
New Environment
Homo sapiens has been around for about 100,000 years,
and both fossils and genomic studies present evidence of
ongoing evolution in H. sapiens. As a species, H. sapiens
has experienced many lifestyle changes—some generated
by culture, others by new or changing environments.
Anthropology can provide valuable insights into our past,
and this information can improve our application of
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evolutionary medicine (Trevathan 2007). We learn from
studies of ancient societies, but also from the few remaining
traditional hunter-gatherer societies and by comparisons
between different societies.
Amajor shift in lifestyle was the development of agriculture.
Agriculture led to many changes, including dietary alterations
and exposure to zoonoses from domesticated animals. Agricul-
ture required groups to abandon a mobile hunter-gatherer
lifestyle and live in sedentary populations, such as farming
villages. Ultimately, agriculture provided the ability to support
large urban populations. Sedentary groups encounter issues
such as accumulation of wastes and transmission of epidemic
diseases (Armelagos et al. 2005), issues that increase with
population size. Even more recently, increases in expected life
span and change in diets have led to a rise in the frequency of
chronic diseases (Armelagos et al. 2005; Leonard 2007).
These changes in the environment and the increase in
population size have the potential to create a surge in the rate
of evolutionary change (Hawks et al. 2007).
Clinicians and biomedical researchers need to incorpo-
rate an understanding of this mismatch to modernity into
their explorations of pathophysiology. In simple terms,
many aspects of our modern environment and lifestyle,
including diet, exercise, exposure to chemicals, hygienic
practices and circumstances, and a variety of other
elements, are mismatched to our bodies’ evolutionary state.
For example, if—thanks to our prehistoric ancestors—our
physiology is evolutionarily hardwired for low caloric
intake and intense physical activity, our rich modern diets
and sedentary lifestyles mismatch our innate metabolism
(Neel 1962; Wang and Mariman 2008). Evolutionary
medicine tells us that many of today’s so-called “diseases
of civilization” that are so highly prevalent and growing
rapidly in incidence, such as diabetes, obesity, and
cardiovascular disease, may well be fueled by a metabolic
mismatch (Leonard 2007). This phenomenon can be readily
observed in contemporary populations that have undergone
a “nutrition transition” in which rapid socioeconomic,
demographic, and technological changes have brought
profound changes in diet and activity patterns, often
resulting in sudden and widespread increases in metabolic
disorders. For example, a recent paper examined the
changes in diet and health in the rapidly urbanizing black
South African population. The study found that the change
in lifestyle was accompanied not only by an improvement
in micronutrients but also by an increase in obesity and
chronic diseases (Vorster et al. 2005). Characterizing such
mismatches through the use of today’s analytical tools
promises to shed important new light on the etiology of
these and many other common, complex disorders (e.g.,
autoimmune, inflammatory, and mental/behavioral condi-
tions) and offers an innovative approach to the identifica-
tion of novel interventions and therapies.
Continuing to look at mismatches between what we are
prepared for evolutionarily and what we experience with a
modern lifestyle, we find puzzling results that require an
understanding of our evolutionary history to solve. For
example, recent studies have demonstrated a connection
between decreased intestinal parasite load and increased
incidence of autoimmune diseases such as asthma (Lau and
Matricardi 2006). In one study, children who had been
dewormed showed an increase in the occurrence of allergic
reactions to house mites. Why? What was the link between
removing worms and developing allergies? One proposed
explanation is the “hygiene hypothesis” (Strachan 1989),
which takes an evolutionary view and considers that the
historically “normal” condition for humans is a constant
barrage of parasites and that the immune response evolved
in response to these conditions. An over-reactive immune
system is a recognized cause of allergies, and it turns out
that the presence of helminthes, common intestinal para-
sites, actually increases regulation and control of the
immune response. When these children were dewormed,
regulation of their immune response decreased, allowing an
allergic response to house mites. An interesting application
of this research is the experimental use of intestinal
parasites in the treatment of autoimmune diseases such as
irritable bowl syndrome, Crohn’s disease, and multiple
sclerosis (Wickelgren 2004).
Evolution can also shed light on normal physiological
responses such as vomiting and fever and guide medical
interventions (Nesse and Williams 1998). In terms of
evolution, a trait will be selected for if it provides some
advantage. An example is “morning sickness”—the nausea
and vomiting suffered by 75% of pregnant women (Badell et
al. 2006). Nausea and vomiting are commonly experienced
in the first and second trimesters, and generally, foods such
as meat, fish, poultry, and eggs elicit the strongest responses.
Clearly, feeling nauseated and vomiting frequently are
unpleasant experiences at the very least, and hospitalization
for rehydration is frequently required. Occasionally, more
serious complications arise. However, there is significant
evidence that this physiological process is associated with
successful pregnancies (Weigel and Weigel 1989). One
tested hypothesis posits that this response is beneficial to
both mother and embryo because it reduces the mother’s
intake of, and embryo’s exposure to, potentially toxic
chemicals and pathogens during key developmental stages
(Flaxman and Sherman 2000). In addition, the foods most
commonly avoided are animal products which tend to harbor
more pathogens than plant foods. The immune system of
pregnant women is depressed to avoid rejection of the fetus,
so both mother and embryo are at higher risk from
pathogens. The benefits of this response may well justify
the discomfort and risks—or at least provide some psycho-
logical comfort to suffering women.
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Evolution of Infectious Disease
Evolution is not something that happened long ago and
then stopped. It remains an active force in the modern
world not only in human populations but also in the
pathogens and parasites with which we live. One need look
no farther than the local news or health clinic for proof. The
evolution of antibiotic-resistant strains of tuberculosis made
the news in spring 2007 when a man with extremely drug-
resistant (XDR) TB made multiple international flights
(CNN 2007). Fortunately, no one else was infected in this
instance, but the recent evolution of drug-resistant TB has
revived old fears, especially in places where the compli-
cated medical treatment required for these strains is not
available. Evolutionary medicine can help physicians take
into account the effects of people’s changing environments
and lifestyles. Human behaviors such as conflict, poverty, and
urbanization provide opportunities for infectious diseases to
spread (Halstead 1996). Today, more people live in areas of
high population density—a change from the more traditional
small community. High population density urban centers are
ideal for transmission of pathogens, particularly when
coupled with high rates of poverty (Armelagos et al. 2005).
Old antagonists are not the only concern. Behaviors that
bring humans into contact with pathogen reservoirs in
wildlife, such as logging and the exotic animal and bush
meat trades, also create opportunities for the transmission
of “zoonoses”—pathogens normally found in animal hosts
but capable of infecting humans (Patz et al. 2004). For
example, logging brings roads to new areas, providing easy
access for local inhabitants who come to hunt for food. In
the process, hunters either become prey themselves as they
are infected by novel pathogens or bring the pathogens
back to populated areas in the form of bush meat (Chomel
et al. 2007). Sometimes, the infection is relatively benign—
for example, children often pick up worms from household
pets—but sometimes, the transfer is deadly. The ancestor of
the human immunodeficiency virus (HIV) is the simian
immunodeficiency virus, which is found in a wide range of
primate species and rarely causes disease in the primate
host (Hahn et al. 2000) despite the fact that HIV is
devastating in humans.
Taking an evolutionary approach to medicine can help us
deal with novel pathogens by increasing our understanding
of the pathogen and facilitating the development of
appropriate responses. When the mysterious severe acute
respiratory syndrome (SARS) virus emerged on the world
scene, researchers quickly gathered information about its
physical structure, life cycle, and genetics. By comparing
its characteristics with those of known viruses, researchers
were able to quickly identify the novel SARS virus as a
coronavirus (WHO 2003). That crucial piece of information
allowed health care professionals to develop appropriate
diagnostic tools, preventive measures, and treatments based
on knowledge of how other coronaviruses behave. Addi-
tionally, the information about viral type allowed field
researchers to identify the source of the infection based on
known hosts of coronaviruses. Civet cats, sold live in meat
markets, were frequently found to be infected with a SARS
virus. Further research indicated that horseshoe bats, which
were also sold in these markets, had a more ancestral
variant of the virus (Britigan 2005; Lau et al. 2005;
Wendong et al. 2005). The virus was also found to be more
widespread in bats. The civet cats probably act as an
intermediate host, or “amplifier.” Understanding the lifestyle
and environment in which the disease arose helped to rapidly
control it, preventing a feared worldwide epidemic.
Genomics, Evolution, and Medicine
Recently, new technologies such as improved genome
sequencing and microarrays are generating huge quantities
of genomic information. Bioinformatic tools for analysis of
this ever-expanding volume of raw data are developing
apace, and genomics, the study of whole genomes, has
become an independent biological discipline. The medically
relevant value of this data is the potential to identify the
genes underlying disease for the purpose of developing
treatment or even prevention. Evolutionary medicine plays a
critical role in the interpretation and application of this
information, since human evolutionary history has shaped
the genome. Humans as a species are relatively young with a
mere 100,000-year history. The pattern of our relatively
recent global dispersal from our home in Africa is reflected
in our genes. Different populations demonstrate our common
ancestry and recent isolation during dispersal (Kidd and
Kidd 2007). Interpretation of genomic data must take our
evolutionary history into account to yield useful applications.
One of the most informative analytical approaches is
comparison between sequences, either of small genomic
regions or entire genomes. By examining differences and
similarities between the genomes of two organisms,
researchers learn about ancient genes that have deep
evolutionary roots and about genetic differences between
organisms that make them unique. In comparing the human
genome with those of closely related primates, we learn
what minor differences may be important keys to our
human condition. Comparisons between the human genome
and more distantly related organisms provide information
about ancient genes that play important roles in fundamen-
tal processes such as development and physiology. This can
be done on various levels. Microarrays allow comparisons
between sets of genes or two entire genomes. Bioinformatic
tools allow comparisons of multiple genes, sections of
genomes, or entire genomes.
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A new method that exploits both microarray technology
and genome sequencing is the genome-wide association
(GWA) study. In a GWA, a microarray of all of the known
human single nucleotide polymorphisms (which are simply
a change in one nucleotide) is screened for differences
between diseased and healthy individuals. To give the study
statistical significance, samples from thousands of individ-
uals are used. In a recent GWA, researchers identified
genomic polymorphisms potentially associated with seven
different diseases (Wellcome 2007). This information can
be used to guide future research on the genetics of these
diseases. The GWA is yet another method based on
enormous data sets that may lead to significant advances
in medicine. Resources to promote this kind of mega-
analysis include the Human Genome Project and the
HapMap, which uses collections of single-nucleotide differ-
ences as markers for larger genetic regions. The HapMap is
important because genomes of any two humans differ only
by 0.1%. Researchers can use the general markers from the
HapMap to narrow down their searches to areas of variation.
An important key to drawing useful information from
genomic data is the ability to link a genotype to a
phenotype. This is a difficult problem for several reasons:
genomic data are not usually collected from a specific
individual with an extensive health history; family medical
histories are rarely complete; environmental conditions vary
between populations, etc. One approach to deal with this
issue is the use of large, long-term studies of specific
populations. The Framingham Heart Study (FHS) is the
quintessential large cohort, long-term study. Initiated in
1948 to investigate the causes of heart disease and stroke,
the project collected data on more than 5,000 people living
in Framingham, Massachusetts. In addition to birth,
marriage, reproduction, and death data, the participants
were given physical exams and lifestyle interviews. Follow-
up physicals were given every 2 years. Adult children of
the original cohort and the children’s spouses, as well as the
original cohort’s grandchildren, also participated in the
study. This study allowed researchers to identify the major
environmental risk factors for cardiovascular disease, such
as smoking and high blood pressure. Because of the
extensive data collected for the project and the virtually
unprecedented length of the study, the FHS is incredibly
valuable to medical researchers. The data are now being
mined by groups researching other diseases such as obesity
and eye and lung diseases. Other studies of large or multi-
generational cohorts are also under way using different
populations.
Diddahally Govindaraju is the director of the FHS
Genetics Laboratory at the Boston University School of
Medicine and was one of the organizers of the NESCent
meeting. He is enthusiastic about the concept of applying
evolutionary principles to cohort data such as that generated
over nearly six decades in the FHS. “I was essentially
sitting on a wealth of medical data that has been collected
for the last 50 years,” he says. “Having been raised on
evolutionary biological thought in the first part of my
professional life, I looked at this and realized that the
doctors were not looking at these data from an evolutionary
biology perspective.” Dr. Govindaraju and his colleagues
have organized a working group to explore the FHS from
an evolutionary viewpoint. The group proposes to look for
microevolutionary changes in the study population and to
use the extensive medical data to correlate differences in
genomic inheritance and phenotypic outcomes.
Given the vast quantities of data available because of the
genomics revolution and multi-generational, longitudinal
clinical cohorts such as the Framingham Heart Study, it has
become increasingly clear that the analysis of new and
existing data from an evolutionary perspective promises to
yield important insights into long-standing questions about
human physiology and pathophysiology. Combined with
the development of new technologies that have given us
entire genomes and the tools with which to study them,
these vast data sets have the potential to launch an
evolutionary medicine revolution.
Ethical Considerations
It should come as no surprise that evolutionary medicine
comes with a unique set of ethical issues. A field that
encompasses so many aspects of who we are as individuals
and has the power to provide better health to so many
people also has the potential to be abused in a variety of
ways. Positive applications such as personalized medicine,
in which an individual would receive the most beneficial
medical treatment based on his or her genomic makeup,
hold great promise for improving the efficacy of medical
care. However, it is no great stretch to imagine that genetic
information about individuals could be misused outside of
the medical realm. Communication of complex evolutionary
medicine concepts to the general public will be fraught with
cultural perspectives, biases, and historical antagonism, and
miscommunication could have serious consequences for
individuals and society.
Privacy concerns are a major issue. When so much data,
including genetic information, are being gathered on so
many people, how can a participating individual’s privacy
be protected while simultaneously making the information
as widely available as possible (NHGRI 2007)? Also, the
use of particular populations in studies is a double-edged
sword. In some cases, researchers can learn a great deal by
studying a particular group whose members share a lifestyle
or ancestry. But how can that group be certain that the
information will not be used against them, by insurance
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companies, for example? On the other hand, if beneficial
information is gleaned from one group, how is that benefit
made available to other groups who were not studied?
Another important issue to consider is the concept of
race (Kittles and Weiss 2003). Particularly in the USA, the
sensitive nature of this issue cannot be overstated. The
genetic concept of race and the social concept of race are
not the same. In colloquial use, the term race designates a
group of people based on their appearance and culture.
Among the research community the definition of race has
not been consistent or well defined. Scientifically, race
correlates roughly with shared genetic ancestry usually
based on geographic proximity, but even these parameters
fail to clearly delineate groups. There is some debate as to
whether race is a legitimate biological concept at all. Social
concepts of race also influence how research is done by
biasing selection of populations to be sampled, methodol-
ogies, and other aspects of research. Paradoxically, some
diseases are associated with socially defined races, such as
Tay–Sachs disease in the Ashkenazi Jews, making it
necessary to take into account these social groupings in
conducting research.
Conclusion
The exciting potential of evolutionary medicine to yield
important new insights into long-standing questions about
human physiology and pathophysiology was summed up by
Stearns: “When you see how evolution illuminates those
questions, you see there’s the potential for a new way of
looking at them to save literally hundreds of millions of lives.
That is an enormous payoff, and it’s the kind of thing that
people in medical research have felt all of their lives, but it’s a
newmotivation for evolutionary biologists, and it’s a revelation
to them to realize that they could bring that to the table.”
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